Omega Healthcare Investors, Inc. Q3 2026 Earnings Recap

Omega’s shares rose 3.5% after earnings, with investors likely responding to the highly accretive PACS transition and the company’s deployment of more than $1 billion in the second half to date. Sequential AFFO and FAD were effectively flat, tempering the positive operating and transaction updates.

Key Takeaways

• Third-quarter AFFO was $0.82 per share and FAD was $0.78; both were effectively flat sequentially, partly due to $563 million of asset sales late in the second quarter.
• The 32-facility transition to PACS raises first-year annual rent by $26.1 million, is expected to add about $0.065 per share in annualized FAD, and includes a $90 million termination fee paid to the prior operator.
• Omega completed $181 million of third-quarter investments: $167 million in real estate acquisitions and $14 million in loan fundings. It said it had allocated more than $1 billion in the second half of the year to date.
• Trailing 12-month operator EBITDAR coverage improved to 1.67x from 1.65x; occupancy edged up to 82.7% from 82.6%.
• The Genesis bankruptcy sale was finalized in October: Omega’s master lease was assumed and assigned to a NewGen affiliate, and Omega received repayment of its DIP loan and a $150 million term loan.